OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes
Roberta Zupo, Fabio Castellana, Francesco Panza, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1695-1695
Open Access | Times Cited: 13

Showing 13 citing articles:

Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study
Sara Volpe, Giuseppe Lisco, Margherita Fanelli, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4673-4673
Open Access | Times Cited: 51

The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity
Roberta Rinaldi, Sara De Nucci, Fabio Castellana, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 825-825
Open Access | Times Cited: 27

Associations of life’s essential 8 with MAFLD and liver fibrosis among US adults: a nationwide cross-section study
Depeng Liang, Jie Zhang, Li Lu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 4

Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease
Francesco Bellanti, Aurelio Lo Buglio, Gianluigi Vendemiale
Metabolites (2023) Vol. 13, Iss. 3, pp. 322-322
Open Access | Times Cited: 9

Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity
Sara De Nucci, Fabio Castellana, Roberta Zupo, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 10

A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight
Giovanni De Pergola, Fabio Castellana, Roberta Zupo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 11

Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome
Devis Pascut, Pablo J. Giraudi, Cristina Banfi, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4

Linea guida per la terapia del sovrappeso e dell’obesità resistenti al trattamento comportamentale nella popolazione adulta con comorbilità metaboliche
Marco Chianelli, Alice Albanese, Marilia Carabotti, et al.
L Endocrinologo (2024) Vol. 25, Iss. 1, pp. 84-106
Closed Access | Times Cited: 1

Endocrine Disruptors and Obesity: An Overview
Isanna Murro, Giuseppe Lisco, Carmen Di Noia, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 22, Iss. 8, pp. 798-806
Closed Access | Times Cited: 7

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
Congling Chen, Yuecheng Zhang, Yujuan Fan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3

Revised Protein Sparing Diet in Obesity and Type 2 Diabetes Mellitus
Raffaele Ivan Cincione, Francesca Losavio, Giuseppe Cibelli, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5325-5325
Open Access | Times Cited: 5

Association between liver steatosis, fibrosis, and the onset of type 2 diabetes in overweight individuals: A fibroscan-based study in Southern Italy
Davide Guido, Nicole Cerabino, Martina Di Chito, et al.
Diabetes Research and Clinical Practice (2024) Vol. 218, pp. 111911-111911
Closed Access

Page 1

Scroll to top